Marcello Arca


Titolo Pubblicato in Anno
Prognostic Value and Relative Cutoffs of Triglycerides Predicting Cardiovascular Outcome in a Large Regional-Based Italian Database JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE 2024
How ANGPTL3 Inhibition Will Help Our Clinical Practice? CURRENT ATHEROSCLEROSIS REPORTS 2023
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia. LIVER INTERNATIONAL 2023
Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography study LA RADIOLOGIA MEDICA 2023
[Identifying possible homozygous familial hypercholesterolemia patients: an Italian experts' opinion] GIORNALE ITALIANO DI CARDIOLOGIA 2023
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE 2023
Consensus document on Lipoprotein(a) from the Italian Society for the Study of Atherosclerosis (SISA) NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2023
Real world evidence: Perspectives from a European Society of Cardiology Cardiovascular Round Table with contribution from the European Medicines Agency EUROPEAN HEART JOURNAL. QUALITY OF CARE & CLINICAL OUTCOMES 2023
Hypertriglyceridemia is associated with decline of estimated glomerular filtration rate and risk of end-stage kidney disease in a real-word Italian cohort: Evidence from the TG-RENAL Study EUROPEAN JOURNAL OF INTERNAL MEDICINE 2023
Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial JOURNAL OF CLINICAL LIPIDOLOGY 2023
Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study THE LANCET REGIONAL HEALTH. EUROPE 2023
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance EUROPEAN HEART JOURNAL SUPPLEMENTS 2023
Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group NUTRIENTS 2023
ANGPTL3 Deficiency and Risk of Hepatic Steatosis CIRCULATION 2023
[How to overcome barriers to implementation of prevention and management strategies of atherosclerotic cardiovascular disease through lipid-lowering therapy] GIORNALE ITALIANO DI CARDIOLOGIA 2023
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study ATHEROSCLEROSIS 2023
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study THE LANCET 2022
The Fibrinogen-like Domain of ANGPTL3 Facilitates Lipolysis in 3T3-L1 Cells by Activating the Intracellular Erk Pathway BIOMOLECULES 2022
ANGPTL3 deficiency associates with the expansion of regulatory T cells with reduced lipid content ATHEROSCLEROSIS 2022
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study FRONTIERS IN GENETICS 2022

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma